文献速递临床试验与 GCP真实世界研究与卫生经济

支持性在线自我管理对比常规照护用于炎症性肠病成人疲劳、疼痛和便急/失禁症状:IBD-BOOST随机对照试验研究方案

Supported online self-management versus care as usual for symptoms of fatigue, pain and urgency/incontinence in adults with inflammatory bowel disease (IBD-BOOST): study protocol for a randomised controlled trial.
PubMed 文献 · Trials · 2021-08-03

本研究为实用性两臂平行组随机对照试验,旨在评估基于认知行为原则、由引导者支持的在线自我管理项目(BOOST)对比常规照护,对报告疲劳、疼痛或便急/失禁症状的炎症性肠病(IBD)成人患者IBD相关生活质量(UK-IBDQ)和症状缓解总体评分(0-10分)的影响。计划随机化680例患者(每组340例),共同主要结局为6个月时的UK-IBDQ和症状缓解总体评分,同时评估6个月和12个月的多项次要结局以评价维持效果。

要点

  • BOOST为12次引导者支持的在线认知行为自我管理项目,针对IBD患者的疲劳、疼痛和便急/失禁症状。
  • 共同主要结局为6个月时UK-IBDQ评分和症状缓解总体评分(0-10分),次要结局在6和12个月评估。
  • 计划随机化680例(每组340例),通过既往大规模调查招募未选择的IBD患者。

核心结论

  • 该方案旨在检验引导者支持的在线自我管理项目能否改善IBD患者的生活质量和症状缓解。

研究设计与样本

  • 实用性两臂平行组随机对照试验,比较12次引导者支持的在线认知行为自我管理项目与常规照护。
  • 计划随机化680例患者,每组340例,通过既往大规模调查招募未选择的IBD患者。
  • 嵌入试点研究、健康经济学评价和过程评价。

关键数值与推荐

  • 共同主要结局为6个月时的UK-IBDQ评分和症状缓解总体评分(0-10分)。
  • 次要结局在随机化后6个月和12个月测量,以评估维持效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite being in clinical remission, many people with inflammatory bowel disease (IBD) live with fatigue, chronic abdominal pain and bowel urgency or incontinence that limit their quality of life. We aim to test the effectiveness of an online self-management programme (BOOST), developed using cognitive behavioural principles and a theoretically informed logic model, and delivered with facilitator support. PRIMARY RESEARCH QUESTION: In people with IBD who report symptoms of fatigue, pain or urgency and express a desire for intervention, does a facilitator-supported tailored (to patient needs) online self-management programme for fatigue, pain and faecal urgency/incontinence improve IBD-related quality of life (measured using the UK-IBDQ) and global rating of symptom relief (0-10 scale) compared with care as usual? METHODS: A pragmatic two-arm, parallel group randomised controlled trial (RCT), of a 12-session facilitator-supported online cognitive behavioural self-management programme versus care as usual to manage symptoms of fatigue, pain and faecal urgency/incontinence in IBD. Patients will be recruited through a previous large-scale survey of unselected people with inflammatory bowel disease. The UK Inflammatory Bowel Disease Questionnaire and global rating of symptom relief at 6 months are the co-primary outcomes, with multiple secondary outcomes measured also at 6 and 12 months post randomisation to assess maintenance. The RCT has an embedded pilot study, health economics evaluation and process evaluation. We will randomise 680 patients, 340 in each group. Demographic characteristics and outcome measures will be presented for both study groups at baseline. The UK-IBDQ and global rating of symptom relief at 6 and 12 months post randomisation will be compared between the study groups. DISCUSSION: The BOOST online self-management programme for people with IBD-related symptoms of fatigue, pain and urgency has been designed to be easily scalable and implemented. If it is shown to improve patients' quality of life, this trial will enable clinicians and patients to make informed management decisions. This is the first trial, to our knowledge, focused on multiple symptoms prioritised by both people with IBD and health professionals. TRIAL REGISTRATION: ISRCTN71618461 . Registered on 9 September 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Norton C, Syred J, Kerry S, et al. Supported online self-management versus care as usual for symptoms of fatigue, pain and urgency/incontinence in adults with inflammatory bowel disease (IBD-BOOST): study protocol for a randomised controlled trial. Trials. 2021. PMID: 34344432. doi:10.1186/s13063-021-05466-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。